Cardiology

Your Article Summary

See Latest Articles

Safety and efficacy of drug-eluting and bare metal stents. Comprehensive meta-analysis of randomized trials and observational studies
Circulation, 06/17/09

Kirtane AJ et al. – Results of randomized controlled trials (RCTs) show no significant differences in long-term rates of death or myocardial infarction after drug-eluting (DES) or bare metal stent (BMS) use for either off- or on-label indications. In real-world nonrandomized observational studies with more pts but potential selection bias, DES use associated with reduced death and myocardial infarction. Both RCTs and observational studies showed marked and comparable reductions in target vessel revascularization with DES vs BMS.

• Meta-analysis of DES studies to estimate relative impact of DES vs BMS on safety and efficacy endpoints
• Focus on non–Food and Drug Administration–labeled indications
• Report on comparative DES vs BMS studies with ≥100 total pts and mortality data with cumulative follow-up of ≥1 yr

• Data review for 9470 pts in 22 RCTs and 182,901 pts in 34 observational studies
• In RCTs, DES (vs BMS) associated with no detectable differences in overall mortality or myocardial infarction, with significant 55% reduction in target vessel revascularization
• Point estimates slightly lower in off- vs on-label analyses
• In observational studies, DES associated with significant reductions in mortality, myocardial infarction, and target vessel revascularization vs BMS

Related Articles

See all related articles

Clinical Outcomes After Sirolimus-Eluting, Paclitaxel-Eluting, and Bare Metal Stents (from the First Phase of the Prospective Multicenter German DES.DE Registry)
The American Journal of Cardiology, 11/09/09    Relevance Score: 88%

Timing of Noncardiac Surgery After Coronary Artery Stenting With Bare Metal or Drug-Eluting Stents
The American Journal of Cardiology, 10/27/09    Relevance Score: 88%

Safety and efficacy of drug-eluting vs. bare metal stents in patients with diabetes mellitus: long-term of follow-up in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
European Heart Journal, 11/18/09    Relevance Score: 87%

Differential Healing After Sirolimus, Paclitaxel, and Bare Metal Stent Placement in Combination With Peroxisome Proliferator-Activator Receptor gamma Agonists. Requirement for mTOR/Akt2 in PPAR-gamma Activation
Circulation Research, 10/02/09    Relevance Score: 87%

Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease
Catheterization and Cardiovascular Interventions, 10/01/09    Relevance Score: 87%

Today in Coronary Artery Disease...keeping you current

Receive free subspecialty "5-minute updates" via email

Apolipoprotein E gene polymorphisms and serum cholesterol in healthy Irish adults: a proposed genetic marker for coronary artery disease risk
Irish Journal of Medical Science, 12/18/09

Influence of Genetic Polymorphism in Matrix Metalloproteinase-3 on Extent of Coronary Atherosclerosis and Risk of Coronary Artery Stenosis
Archives of Medical Research, 12/18/09

High Prevalence of Coronary Heart Disease in Type 2 Diabetic Patients with Non-alcoholic Fatty Liver Disease
Archives of Medical Research, 12/18/09

 See all of Coronary Artery Disease

Today in Interventional...keeping you current

Receive free subspecialty "5-minute updates" via email

Patient Comprehension of an Interactive, Computer-Based Information Program for Cardiac Catheterization
Archives of Internal Medicine, 12/14/09

Prehospital 12-Lead ECG to Triage ST-Elevation Myocardial Infarction and Emergency Department Activation of the Infarct Team Significantly Improves Door-to-Balloon Times
Circulation: Cardiovascular Interventions, 12/03/09

Early Experience with a Simplified Technique for Transcatheter Closure of the Patent Foramen Ovale
Heart, Lung, and Circulation, 11/20/09

 See all of Interventional